Skip to content

Category: Top Stories

‘KPop Demon Hunters’ is boosting more than just Netflix: Korean music, politics ride the craze

Business Men Break Sit Read Newspaper

Analysts say the popularity of “KPop Demon Hunters” could spread to all of K-culture, including cosmetics and food products.

Stocks making the biggest moves midday: Uber, Hertz, Norwegian Cruise, Yum, Palantir and more

Business Men Break Sit Read Newspaper

These are some of the stocks posting the largest moves midday.

Property Play: Commercial real estate deals are slowing, but these two beleaguered sectors are shining

Business Men Break Sit Read Newspaper

CRE deal trends in September reveal several themes: Flight to quality, economic uncertainty hitting the hotel sector hard, and a growing interest in two sectors.

How the market’s bad breadth may have been a harbinger of Tuesday sell-off

Business Men Break Sit Read Newspaper

The market’s weak breadth is starting to catch up to it.

Spotify tops third-quarter estimates on strong user growth, issues mixed guidance

Business Men Break Sit Read Newspaper

The streaming platform had 281 million premium subscribers for the quarter, coming in just below StreetAccount expectations.

Scale AI’s life after Meta deal has been rocky, but CFO insists it’s not a ‘zombie company’

Business Men Break Sit Read Newspaper

Five months after Scale AI’s high-profile founder was hired by Meta, the startup is trying to show that it’s still on a growth trajectory.

Judge asked to force Trump admin to pay full SNAP benefits

Business Men Break Sit Read Newspaper

Prior presidential administrations have continued paying SNAP benefits during past shutdowns of the U.S. government.

Bank of America downgrades gambling stocks, citing threat from prediction markets

Business Men Break Sit Read Newspaper

Online sports betting faces a tough road ahead as competition grows from prediction markets and regulatory uncertainty mounts, accoridng to BofA.

Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

Business Men Break Sit Read Newspaper

The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.

Tuesday, November 4, 2025: Jim Cramer discusses his next moves for the Investing Club

Business Men Break Sit Read Newspaper

Post Content

← Previous
Next →

Ready to take your stock trading to the next level? Sign up now to receive exclusive market analyses, insightful tips, and valuable resources straight to your inbox. Don’t miss out on the opportunity to stay ahead in the ever-evolving world of trading!

JOIN OUR COMMUNITY

Join our growing community of educated investors working together to build wealth with a diversified outlook at investment opportunities

Copyright © 2023. All Rights Reserved.

  • Privacy & Policy
  • Disclaimer